Publications by authors named "Benjamin Greer"

Claim this Profile
P
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study.
Robert F Ozols, Brian N Bundy, Benjamin E Greer, Jeffrey M Fowler, Daniel Clarke-Pearson

J Clin Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weaponizing mutual aid: Can a pandemic or biological attack turn our strongest emergency management tool against us?
Benjamin Thomas Greer

J Emerg Manag· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer.
Krishnansu S Tewari, Robert A Burger, Danielle Enserro, Barbara M Norquist, Elizabeth M Swisher, Benjamin E Greer

J Clin Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vulvar Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.
Wui-Jin Koh, Benjamin E Greer, Nadeem R Abu-Rustum, Susana M Campos, Kathleen R Cho

J Natl Compr Canc Netw· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Framework for Resource Stratification: A Framework for Providing and Improving Global Quality Oncology Care.
Robert W Carlson, Jillian L Scavone, Wui-Jin Koh, Joan S McClure, Benjamin E Greer

J Natl Compr Canc Netw· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New NCCN Guidelines for Vulvar Cancer.
Benjamin E Greer, Wui-Jin Koh

J Natl Compr Canc Netw· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uterine Sarcoma, Version 1.2016: Featured Updates to the NCCN Guidelines.
Wui-Jin Koh, Benjamin E Greer, Nadeem R Abu-Rustum, Sachin M Apte, Susana M Campos

J Natl Compr Canc Netw· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: an NRG Oncology/GOG study.
James S Ferriss, James J Java, Michael A Bookman, Gini F Fleming, Bradley J Monk, Benjamin E Greer

Gynecol Oncol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cervical Cancer, Version 2.2015.
Wui-Jin Koh, Benjamin E Greer, Nadeem R Abu-Rustum, Sachin M Apte, Susana M Campos

J Natl Compr Canc Netw· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for GI adverse events in a phase III randomized trial of bevacizumab in first-line therapy of advanced ovarian cancer: A Gynecologic Oncology Group Study.
Robert A Burger, Mark F Brady, Michael A Bookman, Bradley J Monk, Joan L Walker, Benjamin E Greer

J Clin Oncol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uterine neoplasms, version 1.2014.
Wui-Jin Koh, Benjamin E Greer, Nadeem R Abu-Rustum, Sachin M Apte, Susana M Campos

J Natl Compr Canc Netw· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient reported outcomes of a randomized, placebo-controlled trial of bevacizumab in the front-line treatment of ovarian cancer: a Gynecologic Oncology Group Study.
Bradley J Monk, Helen Q Huang, Robert A Burger, Robert S Mannel, Howard D Homesley, Benjamin E Greer

Gynecol Oncol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cervical cancer.
Wui-Jin Koh, Benjamin E Greer, Nadeem R Abu-Rustum, Sachin M Apte, Susana M Campos

J Natl Compr Canc Netw· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early experiences in establishing a regional quantitative imaging network for PET/CT clinical trials.
Robert K Doot, Tove Thompson, Benjamin E Greer, Keith C Allberg, Hannah M Linden

Magn Reson Imaging· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incorporation of bevacizumab in the primary treatment of ovarian cancer.
Robert A Burger, Mark F Brady, Michael A Bookman, Gini F Fleming, Bradley J Monk, Benjamin E Greer

N Engl J Med· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined weekly topotecan and biweekly bevacizumab in women with platinum-resistant ovarian, peritoneal, or fallopian tube cancer: results of a phase 2 study.
Kathryn F McGonigle, Howard G Muntz, Jacqueline Vuky, Pamela J Paley, Dan S Veljovich, Benjamin E Greer

Cancer· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of bevacizumab in recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study.
Carol Aghajanian, Michael W Sill, Kathleen M Darcy, Benjamin Greer, D Scott McMeekin

J Clin Oncol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group study.
Mark A Morgan, Michael W Sill, Keiichi Fujiwara, Benjamin Greer, Stephen C Rubin

Gynecol Oncol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced stage mucinous adenocarcinoma of the ovary is both rare and highly lethal: a Gynecologic Oncology Group study.
Richard J Zaino, Mark F Brady, Subodh M Lele, Helen Michael, Benjamin Greer

Cancer· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancer.
Ernest S Han, Robert A Burger, Kathleen M Darcy, Michael W Sill, Leslie M Randall, Benjamin E Greer

Gynecol Oncol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cervical cancer.
Benjamin E Greer, Wui-Jin Koh, Nadeem R Abu-Rustum, Sachin M Apte, Susana M Campos

J Natl Compr Canc Netw· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian cancers: a Gynecologic Oncology Group Study.
John Farley, Sartoru Fuchiuji, Kathleen M Darcy, Chunqiao Tian, William J Hoskins, Benjamin E Greer

Gynecol Oncol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uterine Neoplasms. Clinical Practice Guidelines in Oncology.
Benjamin E Greer, Wui-Jin Koh, Nadeem Abu-Rustum, Michael A Bookman, Robert E Bristow

J Natl Compr Canc Netw· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian cancer. Clinical practice guidelines in oncology.
Robert J Morgan, Ronald D Alvarez, Deborah K Armstrong, Barry Boston, Lee-may Chen, Benjamin E Greer

J Natl Compr Canc Netw· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cervical cancer screening.
Edward E Partridge, Nadeem Abu-Rustum, Susan Campos, Patrick J Fahey, Benjamin E Greer

J Natl Compr Canc Netw· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis